OCON Therapeutics, a pioneer recognized by the World Economic Forum for its advancements in drug delivery, has announced a significant milestone with the completion of a $10 million investment round led by RH Capital. This funding marks a pivotal moment for OCON as it accelerates efforts to redefine the standard of care in women’s health…
Better Juice, Ltd., a pioneering foodTech company, has introduced a game-changing innovation aimed at revolutionizing the sorbet and fruit ice cream market. Leveraging their advanced enzymatic technology, Better Juice has successfully reduced the sugar content in fruit sorbets by up to 70%, offering health-conscious consumers a guilt-free option for indulgence. The launch marks a significant…
Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…
FREYR Battery (NYSE: FREY), a leading developer in clean, next-generation battery cell production, has reached a significant milestone in its operations with the successful completion of its first production trial at the Customer Qualification Plant (“CQP”) in Mo i Rana, Norway. This accomplishment marks FREYR as the first company to achieve automated production trials on…
VoltR Advances Sustainable Lithium Battery Manufacturing with €4 Million Seed Funding VoltR, a pioneering French deep-tech company specializing in sustainable lithium batteries, has successfully raised €4 million in seed funding to scale its innovative processes. The funding round, led by prominent investors including C4 Ventures, Exergon, Pays de la Loire Participations, and Anjou Amorçage, marks…
Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…
In a groundbreaking move for the tech startup scene, Berlin-based mika has successfully raised €800k in pre-seed funding to bolster its mission of simplifying accounting and tax obligations for small and medium enterprises (SMEs). Led by the strategic alliance Samen Slimmer, comprising Keen Venture Partners, DFF, and Slimmer AI, this investment marks a pivotal moment…
Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…
PolTREG S.A., a pioneering biotechnology firm specializing in cellular therapies for autoimmune disorders, has announced groundbreaking findings from its long-term clinical study on PTG-007, a polyclonal Treg cell therapy for early-onset type-1 diabetes (T1D). Over a span of 7 to 12 years, pediatric patients treated with PTG-007 demonstrated sustained insulin secretion, contrasting starkly with a…
Singapore-based fintech startup SoSoValue has announced the successful closure of a $4.15 million seed funding round, led by prominent investors including HongShan, GSR Markets, Alumni Ventures, CoinSummer Labs, and One Piece Labs. Noteworthy contributions also came from co-founders of leading Web3 and AI technology firms, alongside early backers of Ethereum and Gitcoin. Founded with a…
